Search

Background: The pre-transplant administration of donor antigens to recipients is reported to prolong transplanted organ survival. We investigated the effect of pre-transplant intraportal administration of recipient blood on rat hepatic allograft survival. Materials and methods: Male LEW (RT1l) and ACI (RT1a) rats were used as transplant recipients and donors, respectively. Before transplantation, donors were transfused with recipient blood. Experimental animals were divided into groups as follows: group I, no treatment; group II, pre-treatment with recipient blood via the penile vein 7 days before transplantation; group III, pre-treatment with recipient blood via the portal vein 5 days before transplantation; and group IV, pre-treatment with recipient blood via the portal vein 7 days before transplantation. Serum interferon (IFN)-γ concentrations were measured post-operatively. Results: Animals in group I survived a mean of 10.1 ± 0.7 days. The survival of groups II and III was 10.6 ± 1.6 and 13.1 ± 0.9 days, respectively. The survival rate in group IV was prolonged significantly to 33.7 ± 2.6 days. Serum concentrations of IFN-γ were increased significantly in group IV, as compared with group I. The ratio of OX76+CD4+ or OX76+CD8+ T cells to OX76-CD4+ or OX76-CD8+ T cells was greater in group IV, as compared group I. OX76+CD8+ T cells from hepatic allografts in group IV expressed IFN-γ and interleukin (IL)-10, but not IL-2 mRNA. Apoptotic hepatic infiltrates were greater in group IV, as compared to group I. Conclusion: The cytokine profile of donor CD8+ T cells from allografts treated by the intraportal administration of recipient blood is associated with apoptosis of graft-infiltrating cells and the prolonged survival of hepatic allografts in rats. [Copyright &y& Elsevier]

Donor dendritic cells (DC) migrate into the recipient spleen after hepatic transplantation. Immunological unresponsiveness to rat hepatic allografts can be induced by prior donor-specific blood transfusion (DST). We investigated homing receptor phenotype and splenic distribution of donor DC after allografting and DST. Immunostaining revealed OX62+ cells in the splenic red pulp of animals receiving pre-transplant DST but only in the white pulp of untreated animals. Most OX62 cells were positive for OX76. There were two subsets of DC in the spleen, CD45RChighOX62+ and CD45RClowOX62+ cells. RT-PCR revealed that CD45RClowOX62+ cells expressed interleukin (IL)-10, while CD45RChighOX62+ cells expressed IL-2 and low levels of IL-10 mRNA. CD45RChighOX62+ cells strongly expressed CCR5 and CCR7, compared with weak expression in CD45RClowOX62+ cells. The Epstein-Barr virus-induced molecule 1 (EBI-1) ligand chemokine (ELC/MIP3β) was expressed mainly within the splenic white pulp. Mucosal vascular addressin-cell adhesion molecule-1 (MAdCAM-1) was expressed in the marginal zone and white pulp, but expression of splenic MAdCAM-1 was down-regulated in DST-treated animals. L-selectin (CD62L), the ligand for MAdCAM-1, was strongly expressed on CD45RChighOX62+ cells but not on CD45RClowOX62+ cells. In conclusion, differential splenic migration of CCR5lowCCR7lowCD62Llow CD45RClow DC expressing Th2-type cytokines is associated with immunological unresponsiveness to rat hepatic allografts. [Copyright &y& Elsevier]

Background: Fatty split-liver and living-related liver transplantation is associated with massive hepatocellular necrosis during acute rejection. Uncoupling protein (UCP)-2 is a potential regulator of energy expenditure and ATP production. We investigated the role of UCP-2 and the effects of a metalloprotease inhibitor, Y-39083, on hepatocellular injury in fatty liver allografts in rats.Materials and methods: Rats were treated for 6 weeks with high-ethanol or isocalic dextrose-containing liquid diets that caused characteristic pericentral lipid accumulation. Alcoholic or nonalcoholic fatty livers from ACI (RT1a) rats were transplanted into LEW (RT1l) rats orthotopically. Hepatic necrosis was determined histologically following liver transplantation. UCP-2 mRNA levels in the hepatic allograft and in primary cultured hepatocytes from fatty liver stimulated by tumor necrosis factor (TNF)-α were determined. Y-39083 was administered to recipient rats continuously at 5 mg/kg/day using an osmotic infusion mini-pump.Results: The acute rejection index on day 5 posttransplant in alcoholic and nonalcoholic fatty donor livers was higher than in lean grafts. Massive hepatocyte necrosis was more prominent in alcoholic than nonalcoholic fatty liver allografts and was not seen in lean allografts. UCP-2 transcripts in both alcoholic and nonalcoholic fatty liver allografts were higher than in lean allografts. Serum TNF-α concentrations in recipient rats with either fatty liver allograft were greater than in animals with lean allografts. In vitro UCP-2 mRNA levels in primary cultured hepatocytes from both alcoholic and nonalcoholic fatty livers increased more after stimulation with TNF-α than those from lean livers. In vitro TNF-α production by Kupffer cells isolated from alcohol-induced fatty liver allografts on day 3 posttransplant was greater than those from lean allografts. Y-39083 significantly reduced serum concentrations of TNF-α and prevented massive hepatocellular necrosis in rats with both alcoholic and nonalcoholic fatty liver allografts.Conclusion: Liver grafts with steatosis up-regulated UCP-2. TNF-α further enhanced UCP-2 transcripts, inducing massive hepatocellular necrosis during acute rejection. Posttransplantation necrosis may be prevented by metalloprotease inhibitors. [Copyright &y& Elsevier]

Background: We investigated the effect of the pretransplant administration of recipient''s blood to donor on rat hepatic allograft survival. Methods: Serum levels of interferon (IFN)-γ were determined after transplantation. Immunocompetent cells from the donor were identified with anti-donor class II MHC (RT1Ba) (OX-76) antibodies. The number of donor-derived CD4+ and CD8+ T cells in hepatic allografts or recipient spleen was determined. Results: LEW rats transplanted with hepatic allografts from ACI rats survived a mean of 11.1±2.1 days. Pretreatment intravenous administration of recipient LEW blood did not prolong the survival of hepatic allografts (10.5±1.7 days). In contrast, pretreatment intraportal administration of recipient LEW blood significantly increased the survival of LEW recipients with ACI livers to 31.7±7.6 days (Table 1). The ratio of ox76+CD4+ or ox76+CD8+ T cell to CD4+ or CD8+ cell was significantly greater (25.6% versus 5.7%, 26.6% versus 6.8%) in hepatic allografts pretreated with pretransplant intraportal administration of LEW recipient blood, rather than those cells in recipient spleen (46.2% versus 34.4%, 63.7% versus 71.4%). Conclusions: Pretransplant intraportal administration of recipient LEW blood to ACI donor rats prolonged the survival of hepatic allografts. This may be associated with the regional graft-versus-host reaction. [Copyright &y& Elsevier]